cGxP.wire https://validator.w3.org/feed/docs/rss2.html NervGen Doses First Participant in Phase 3 RESTORE Trial of NVG-291 ANI Pharmaceuticals Reports Positive ILUVIEN Phase 4 Trial Results First Tracks Reports Positive ANB033 Phase 1b Celiac Data BridgeBio Reports Real-World Acoramidis Benefits in ATTR-CM Cardurion Reports Phase 2 Tovinontrine Results in Heart Failure Claris Bio Reports Positive CSB-001 Data in LSCD Study BridgeBio Reports Encaleret Benefits in Phase 3 ADH1 Trial First Tracks Biotherapeutics to Report ANB033 Celiac Data Leads Biolabs Wins FDA Fast Track for Opamtistomig Idorsia Reports Aprocitentan Benefits in Obesity and CKM Sling Therapeutics Reports Durable Linsitinib Results in TED Trial Quince Rebrands as IRulya to Advance Pulmonary Drug Pipeline HCW Biologics Targets 2027 IND Filing for Solid Tumor Therapy Milestone Advances Etripamil Phase 3 Trial in Europe Teva Wins FDA Approval for Once-Monthly WELTRUZA Injection AnX Robotica Reports ProScan AI Workflow Performance Data Celltrion Reports New ZYMFENTRA Data in Crohn’s Disease AbbVie Reports New SKYRIZI and RINVOQ IBD Data Sebela Reports Phase 3 Tegoprazan Data for Reflux Disease Asahi Kasei Wins FDA Approval for HOVILPRI HSV Therapy Genentech Reports One-Year Vamikibart Data in Eye Disease Akeso Starts Phase 3 Cadonilimab Trial in Colon Cancer Vir Biotechnology’s VIR-5500 Gets FDA Fast Track Designation BioMarin Shares New Data on Rare Skeletal Disease Research Bristol Myers Squibb Reports ZENBEXUS Phase 3 Success Johnson & Johnson Reports Two-Year ICOTYDE Psoriasis Data Lilly Reports New Taltz and Zepbound Phase 3b Study Insights Everest Medicines Expands Global mRNA Cancer Vaccine Research Antengene Advances ATG-207 for Autoimmune Disease Research cAMPfield: Prifemilast Wins Phase 3 Psoriasis Trial Results Sagimet Reports 52-Week Denifanstat Acne Trial Results Agenus Wins First Global BOT+BAL Approvals in Armenia Teva Wins FDA Approval for Once-Monthly WELTRUZA Injection AviadoBio Reports Promising AVB-101 Biomarker Data in FTD Guardant Health Wins EU Approval for Breast Cancer Test Genentech Wins FDA Approval for Tecentriq in Stage III Colon Cancer Cullinan Therapeutics Doses First Patient in CLN-049 Phase 2 Newron Reviews FDA Clinical Hold on Evenamide Phase 3 Trial Lupin Wins FDA Approval for Phytonadione Injection Editas Medicine Clears EDIT-401 for First Human Trial Viatris to Acquire Pacira for $1.65 Billion Solu Therapeutics Begins STX-0712 Dosing in AML Cohort Lisata Therapeutics Secures New Certepetide Patent Innovent’s SYCUME Meets Phase 3 Goal in Inactive TED Life Biosciences Reports Initial ER-100 Phase 1 Data Pharvaris Reports Positive Phase 3 Deucrictibant Results Ultragenyx to Sell Rare Disease Voucher for $210 Million Roche Wins FDA Approval for Tecentriq in Stage III Colon Cancer Alpheus Medical Opens New Trial for Butterfly Glioblastoma Alumis Reports Durable Phase 3 Psoriasis Benefits With Envudeucitinib